...
首页> 外文期刊>Therapeutic hypothermia and temperature management >A Single Injection of N-Oleoyldopamine, an Endogenous Agonist for Transient Receptor Potential Vanilloid-1, Induced Brain Hypothermia, but No Neuroprotective Effects in Experimentally Induced Cerebral Ischemia in Rats
【24h】

A Single Injection of N-Oleoyldopamine, an Endogenous Agonist for Transient Receptor Potential Vanilloid-1, Induced Brain Hypothermia, but No Neuroprotective Effects in Experimentally Induced Cerebral Ischemia in Rats

机译:单一注射N-Oleoydopamine,一种内源性激动剂,用于瞬态受体潜在的香草1,诱导的脑体温量,但在实验诱导的大鼠脑缺血中没有神经保护作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Targeted temperature management, or therapeutic hypothermia, is a potent neuroprotective approach after ischemic brain injury. Hypothermia should be induced as soon as possible after the onset of acute stroke to assure better outcomes. Accordingly, drugs with a fast-acting hypothermic effect sustainable through the period of emergency transportation to hospital would have clinical advantages. Activation of the transient receptor potential vanilloid-1 (TRPV1) can induce hypothermia. Our immunohistochemical investigations confirmed that TRPV1 was distributed to perivascular and periventricular regions of the rat brain, where TRPV1 can be easily detected by TRPV1 agonists. An endogenous TRPV1 selective agonist, N-oleoyldopamine (OLDA), and a synthetic antagonist, AMG 9810, were injected intraperitoneally into healthy adult male Wister rats, and brain and core temperatures and gross motor activities were monitored. Comparison with baseline temperatures showed that TRPV1 injection immediately induced mild hypothermia (p < 0.05 in brain and p < 0.01 in body), and AMG 9810 induced immediate mild hyperthermia (not significant). However, the OLDA-induced hypothermia did not decrease lesion volume after middle carotid artery occlusion in rats. Relative to vehicle, OLDA yielded poorer outcomes and AMG 9810 yielded better outcomes in neurological scores and lesion size. Our study showed that, as an agonist of TRPV1, OLDA has suitable hypothermia-inducing properties, but did not decrease lesion volume. Therefore, the search for novel TRPV1 agonists and/or antagonists providing hypothermia and neuroprotection should continue. Further investigations should also target OLDA-induced transient hypothermia combined with long-term hypothermia maintenance with surface cooling, which mimics the anticipated clinical use of this class of drug.
机译:目标温度管理或治疗性低温是一种缺血性脑损伤后的有效的神经保护方法。在急性中风发作后应尽快诱发体温过低,以确保更好的结果。因此,通过对医院紧急运输期间可持续的具有快速发挥的低温效果的药物将具有临床优势。激活瞬时受体潜在的香草醇-1(TRPV1)可以诱导体温过低。我们的免疫组织化学研究证实,TRPV1分布到大鼠脑的羽毛状和脑室区域,其中TRPV1通过TRPV1激动剂容易检测到TRPV1。内源性TRPV1选择性激动剂,N-OXEODODOPAMINE(OLDA)和合成拮抗剂,AMG 9810被腹膜内注射到健康的成年雄性抗探伤大鼠中,并监测大脑和核心温度和总机动性。与基线温度的比较表明,TRPV1注射立即诱导诱导温和的体温过低(脑中的P <0.05和体内P <0.01),AMG 9810诱导立即轻度热疗(不显着)。然而,在大鼠中颈动脉闭塞后,古老诱导的体积没有降低病变体积。相对于载体,奥尔巴产生较差的结果,AMG 9810在神经学评数和病变大小产生更好的结果。我们的研究表明,作为TRPV1的激动剂,Olda具有合适的低温诱导性质,但没有降低病变体积。因此,应继续寻找新的TRPV1激动剂和/或拮抗剂,提供低温和神经保护作用。进一步的调查还应靶向古老的瞬时低温,结合具有表面冷却的长期低温维持,模拟了这类药物的预期临床使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号